[New anti-parkinsonian drugs].
Ogawa
N
N
Institute for Neurobiology, Okayama University Medical School, Japan.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D006801:Humans; D008090:Lisuride / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000627:therapeutic use; D010848:Picolinic Acids / Q000627:therapeutic use; D012642:Selegiline / Q000627:therapeutic use
D000978:Antiparkinson Agents; D010848:Picolinic Acids; D010479:Pergolide; D012642:Selegiline; D001971:Bromocriptine; C059303:lazabemide; D008090:Lisuride